This is the authors' abstract. We don't add key points for this paper.
Respiratory syncytial virus (RSV) is a common cause of lower respiratory tract disease (LRTD) among adults and can lead to serious morbidity and mortality; however, evidence on the magnitude of the public health and economic burden of adult RSV-LRTD is limited. This study was undertaken to project annual clinical outcomes and economic costs of medically attended RSV-LRTD among US adults, and to identify subgroups responsible for a disproportionate share of disease burden.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Averin et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: